Full text is available at the source.
Abstract
The study compares sleeve gastrectomy, semaglutide therapy, and the DEAR weight management program in patients with endometrial cancer.
- Weight control and metabolic improvement outcomes are assessed across the three interventions.
- The efficacy of sleeve gastrectomy, semaglutide therapy, and the DEAR program is evaluated for oncological outcomes.
- Patients receiving fertility-sparing treatment for endometrial cancer are the focus of this comparison.
Simplified